Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001137 · ClinicalTrials.gov registry record
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
A clinical trial, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- Completed
- Registry status
- 5,982
- Enrollment target
NCT00001137 is a clinical trial that has completed, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 5,982 participants.
The verdict
NCT00001137 has completed, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- COMPLETED
- Registry status
- 5,982 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,982 participants |
| Start Date | 2000-01 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001137
The ClinicalTrials.gov registry entry for NCT00001137 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,982 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001137 about?
NCT00001137 is a clinical study titled "Long-Term Data Collection From Participants in Adult AIDS Clinical Trials". The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.
What is the current status of trial NCT00001137?
This trial is currently completed. The enrollment target is 5,982 participants. The study started on 2000-01. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT00001137?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.